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Is One Better Than Two?
T1 Mapping in Myocarditis*Leah M. Iles, MB, CHB, Andrew J. Taylor, PHDMelbourne, Australia“Everything should be made as simple as possible,
but not simpler”dEinstein’s razor (1)
Acute myocarditis is an important differential
diagnosis for patients presenting with chest pain and/
or dyspnea, not only because of its relatively common
incidence (2), but also because of risks of arrhythmia,
sudden cardiac death, and future cardiomyopathy.
Although endomyocardial biopsy is advocated in
patients with deteriorating cardiac function (3), until
recently, the diagnosis was often made on clinical
grounds, largely because of the lack of a reliable
noninvasive test. Over the last decade, cardiac mag-
netic resonance (CMR) imaging has sought to ﬁll
this diagnostic void. T1-weighted (T1W-CMR)See page 1048imaging following gadolinium contrast administra-
tion can identify myocardial hyperemia through
elevated early relative enhancement (ERE), and
regional necrosis may be identiﬁed by late gadolin-
ium enhancement (LGE). In addition, increased
signal on T2-weighted imaging (T2W-CMR) can
demonstrate myocardial edema. The presence of any
2 of myocardial edema, elevated ERE, or LGE on
CMR is by consensus deemed to support a diagnosis
of myocarditis in the appropriate clinical setting (the
“Lake Louise criteria”) (4), and offers improved*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
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of this paper to disclose.diagnostic accuracy over any 1 of these CMR features
in isolation. However, the improved diagnostic
accuracy of multisequential CMR over a single-
sequence approach comes at the cost of in-
creased scan time, additional post-processing, and
requirement for intravenous contrast. It is in this
context that the ﬁndings reported in this issue of
iJACC are of particular relevance.
Ferreira et al. (5) used CMR to evaluate 50 pa-
tients with clinically suspected myocarditis and
compared the ﬁndings with 45 controls. They
assessed LGE and conventional dark-blood T2W-
CMR, and in addition, employed the novel tech-
niques of native T1 mapping and bright-blood
T2W-CMR, the latter of which has some technical
advantages over dark-blood T2W-CMR and has
been shown to correlate with acute myocardial
edema (6). They aimed to establish whether these
methods would improve diagnostic accuracy beyond
that of current sequences. All CMR ﬁndings were
signiﬁcantly different in patients compared with the
control group, with T1 mapping (using a diagnostic
cutoff of$990 ms) and the presence of LGE having
the highest sensitivity (90% and 74%, respectively),
speciﬁcity (91% and 97%), and diagnostic accuracy
(91% and 83%). The combination of LGE and T1
mapping did not improve the diagnostic perfor-
mance of LGE alone, but was superior to the com-
bined results of T2W-CMR techniques with LGE.
The authors conclude that native T1 mapping in
isolation can detect myocarditis with a high diag-
nostic accuracy and is superior to T2W-CMR.
Ferreira et al. (5) are to be commended on studying
novel CMR techniques in a condition that is often
difﬁcult to diagnose with reasonable certainty, both
clinically and with currently applied CMR sequences.
Noncontrast T1 mapping performed well in this
study, and may be of particular relevance in patients
unable to receive gadolinium-based contrast.
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1060Signiﬁcant overlap would be expected between native
T1 mapping and LGE, which are both heavily T1
dependent, as reﬂected in regional assessment of
T1 times. In patients with myocarditis, native T1
times were longer than those of control patients in
areas of myocardium with and also without LGE.
Interestingly, even in areas that appear normal with
LGE and T2W-CMR imaging, the T1 time was
lengthened compared with controls, suggesting that
these regions may be involved on a microscopic level.
The mechanism for prolongation of pre-contrast T1
time in acute myocarditis is unclear; however, it
seems plausible that this reﬂects an increase in both
intracellular and extracellular water content, consis-
tent with previous studies showing a correlation in
other causes of myocardial edema (6,7), and may
possibly be related to potential T2 effects in the T1
mapping sequence (8).
The diagnostic accuracy of 91% of native T1
mapping demonstrated by Ferreira et al. (5) com-
pares favorably with that demonstrated in previous
CMR myocarditis studies using the Lake Louise
criteria, which had a diagnostic accuracy of 85% in
1 single-center study and 78% in pooled studies (4).
It would be tempting to assert that 1 single measure
of native myocardial T1 time might be superior to
any other currently advocated single measure or
combination of CMR measures used to diagnose
myocarditis. From a clinical perspective, 1 single,
reliable CMR measure to diagnose myocarditis
would offer considerable advantages with respect to
simplicity and speed of acquisition, with no need
for contrast administration. However, Ferreira et al.
(5) demonstrate prudence on this matter when
discussing their ﬁndings, and with good reason.
The authors could not directly compare the diag-
nostic accuracy of native T1 mapping with the
consensus recommendation for CMR assessment of
acute myocarditis because of the omission of ERE
from their protocol. The performance of T1W-
CMR pre- and post-contrast evaluation was not
performed because of an already lengthy CMR
examination; however, a direct comparison between
native T1 mapping with the Lake Louise CMR
criteria would be a more clinically applicable
assessment. Myocardial T2 mapping is another
noncontrast quantitative technique for assessment
of water content that also circumvents the need for
reference skeletal muscle. This may perform better
than either of the T2W sequences assessed in this
study; however, as yet, there are no comparative
data of T1 and T2 mapping in this patient
population. Another limitation is the lack ofhistopathology to support the diagnosis of
myocarditis, a limitation shared by many papers
evaluating the diagnostic utility of CMR. Although
the drawbacks of endomyocardial biopsy are well
documented in terms of sampling error, interpre-
tation, and small risk of complications, it can still
provide compelling diagnostic information that
cannot be obtained noninvasively, which is espe-
cially important if steroid-responsive conditions
such as giant cell myocarditis are considered.
Furthermore, when offered a CMR approach to the
diagnosis of myocarditis validated only against
clinical criteria and not histology, a non-CMR
physician might rightly question what CMR can
offer in a diagnostic sense above standard clinical
assessment. Finally, the ﬁndings of Ferreira et al.
(5) will need to be conﬁrmed by additional CMR
studies from independent groups, and the utility of
T1 mapping should be evaluated not only in its
ability to discern patients with acute myocarditis
from healthy controls, but more importantly,
against patients with other forms of cardiac disease
with a similar presentation, such as new-onset
cardiomyopathy. This latter group of patients is
especially problematic using a T1 mapping–based
approach, given the documented efﬁcacy of both
native (9) and post-contrast T1 mapping (10,11) in
identiﬁcation of diffuse myocardial ﬁbrosis, which is
a hallmark of cardiomyopathy.
Before the advent of CMR in the assessment
of myocarditis, many patients were unable to be
conﬁdently diagnosed without myocardial biopsy.
More recently, we have been able to greatly
enhance our noninvasive diagnostic certainty with
tissue characterization made possible by CMR;
however, the range and combinations of CMR
sequences and the supporting data can be
bafﬂing to the non-CMR physician. It is an
appealing notion that in the future 1 single
CMR sequence with high diagnostic accuracy
might overcome much of the uncertainty and
confusion that stems from the current multi-
sequential approach. To this end, the work of
Ferreira et al. (5) has made a signiﬁcant contri-
bution; however, much more work is required in
our quest for diagnostic certainty in the CMR
diagnosis of acute myocarditis.
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